About Rajasthan Antibiotics
Rajasthan Antibiotics is a Healthcare company based in Delhi (India) founded in 1991. It produces and exports sterile APIs like antibiotics and inhibitors worldwide. It operates on a B2B and Manufacturing model. The company has 314 employees. Its Indian entity Rajasthan Antibiotics Ltd reported revenue of ₹383 Cr. Rajasthan Antibiotics offers products and services including Omeprazole Sodium Sterile, Esomeprazole Sodium Sterile, Pantoprazole Sodium Sterile, Meropenem Sodium Sterile, and Vancomycin Hydrochloride Sterile. Its focus areas include Pharmaceuticals, API Manufacturing, Sterile APIs and Antibiotics. Its competitors include Gland Pharma and Nitin Lifesciences.
Company details
Rajasthan Antibiotics Limited specializes in manufacturing sterile Active Pharmaceutical Ingredients (APIs) in advanced facilities in India. They produce products such as proton pump inhibitors and antibiotics, following cGMP, WHO-GMP, and FDA guidelines. The company exports to international markets, serving pharmaceutical firms with high-quality APIs and intermediates. With over 30 years of experience, they emphasize innovation, quality control, and regulatory compliance.
- Headquarters Delhi, India
- Employees 314
- SectorsHealthcare
- Email••••••••
- Website rallife.com
- Social X Facebook
- Legal Name Rajasthan Antibiotics Limited
- Date of Incorporation 17 Mar, 1986
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹383 Cr
FY 2025
- Net Profit₹23.52 Cr
FY 2025 · 6% margin
- EBITDA₹35.90 Cr
FY 2025 · 9% margin
- Employee Count314
Associated legal entities of Rajasthan Antibiotics
Rajasthan Antibiotics is associated with 2 registered companies on The Company Check; the primary company is Rajasthan Antibiotics Ltd. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rajasthan Antibiotics Ltd CIN U24231DL1986PLC023616 | Active | 17 Mar 1986 | New Delhi, Delhi | ₹383 Cr | 314 | 7 | View details |
| Renesa Exports Private Limited CIN U15203CH1999PTC023131 | Active | 03 Dec 1999 | Chandigarh, Chandigarh | ₹1.3 Cr | 2 | View details |
Products & Services of Rajasthan Antibiotics
Rajasthan Antibiotics offers a comprehensive portfolio of products and services, including Omeprazole Sodium Sterile, Esomeprazole Sodium Sterile, Pantoprazole Sodium Sterile, Meropenem Sodium Sterile, and Vancomycin Hydrochloride Sterile.
Treats acid-related stomach conditions effectively.
Manages gastroesophageal reflux and related disorders.
Reduces stomach acid for ulcer and reflux treatment.
Fights bacterial infections in clinical settings.
Used for treating serious infections like MRSA.
Provides broad-spectrum treatment for bacterial diseases.
Combats resistant bacteria in hospital environments.
Treats respiratory and skin infections effectively.
Board of directors of Rajasthan Antibiotics Ltd (Rajasthan Antibiotics)
Rajasthan Antibiotics Ltd is the primary company behind Rajasthan Antibiotics. The boards of the 2 registered companies of Rajasthan Antibiotics currently have 8 directors; the longest-serving is Aashish Pruthii, appointed in 2007. 22 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Aashish Pruthii DIN 01182469 | Managing Director | 01 Jan 2007 | 19 yrs 10 mo | Rajasthan Antibiotics Ltd |
| Rakesh Kumar Girdhar DIN 02380490 | Whole-time director | 01 Nov 2008 | 18 yrs | Rajasthan Antibiotics Ltd |
| Rajvir Singh Rana DIN 03592211 | Director | 05 Aug 2011 | 15 yrs 2 mo | Renesa Exports Private Limited |
| Rajesh Kumar Jha DIN 08345857 | Director | 29 Jan 2019 | 7 yrs 9 mo | Rajasthan Antibiotics Ltd |
| Hans Raj DIN 07596086 | Director | 19 Nov 2020 | 5 yrs 11 mo | Renesa Exports Private Limited |
| Bindu Acharya DIN 07223003 | Director | 03 Jan 2022 | 4 yrs 9 mo | Rajasthan Antibiotics Ltd |
| Vijaysinh Vanvirsinh Chauhan DIN 07105066 | Director | 19 May 2022 | 4 yrs 5 mo | Rajasthan Antibiotics Ltd |
| Arvind Kharabanda DIN 00052270 | Director | 19 May 2022 | 4 yrs 5 mo | Rajasthan Antibiotics Ltd |
Financials of Rajasthan Antibiotics
Figures of Rajasthan Antibiotics Ltd, the primary company behind Rajasthan Antibiotics, for FY 2025. Revenue was ₹383 Cr. Net profit was ₹23.52 Cr (6% margin). EBITDA was ₹35.90 Cr (9% margin).
- ₹383 CrRevenue · FY 2025
- ₹23.52 CrNet profit · 6% margin
- ₹35.90 CrEBITDA · 9% margin
- ₹9.57 CrPaid-up capital
- 314Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Rajasthan Antibiotics Ltd are on its company page.
Detailed financial statements for Rajasthan Antibiotics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Rajasthan Antibiotics
Rajasthan Antibiotics has 2 listed competitors in our database. They include Gland Pharma and Nitin Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| glandpharma.com | 1978 | Hyderabad, India | 4,319 | Generic injectable drugs are manufactured across therapeutic segments. | ||
| nitinlifesciences.com | 1994 | Karnal, India | 56 | CMO of small volume parenteral injectables |
Detailed competitors of Rajasthan Antibiotics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rajasthan Antibiotics
Complete news archive for Rajasthan Antibiotics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajasthan Antibiotics
Rajasthan Antibiotics was founded in 1991.
Rajasthan Antibiotics is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Rajasthan Antibiotics has 314 employees.
The primary company behind Rajasthan Antibiotics, Rajasthan Antibiotics Ltd, reported revenue of ₹383 Cr for FY 2025.
Rajasthan Antibiotics Limited specializes in manufacturing sterile Active Pharmaceutical Ingredients (APIs) in advanced facilities in India. They produce products such as proton pump inhibitors and antibiotics, following cGMP, WHO-GMP, and FDA guidelines. The company exports to international markets, serving pharmaceutical firms with high-quality APIs and intermediates. With over 30 years of experience, they emphasize innovation, quality control, and regulatory compliance.
Rajasthan Antibiotics's top competitors include Gland Pharma and Nitin Lifesciences.
Rajasthan Antibiotics offers Omeprazole Sodium Sterile, Esomeprazole Sodium Sterile, Pantoprazole Sodium Sterile, Meropenem Sodium Sterile, and 4 more products and services.
Rajasthan Antibiotics is associated with 2 legal entities: Rajasthan Antibiotics Ltd, Renesa Exports Private Limited.
The legal entities of Rajasthan Antibiotics currently have 9 directors, including Hans Raj, Rajvir Singh Rana, Aashish Pruthii and others.